M5S-13923-07138
3 vaccinations
7 coded responses
26 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 531 / WI
- Registered
- 2021-02-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-11
Dose 1 — Pfizer-BioNTech
-
2021-02-01
Dose 2 — Pfizer-BioNTech
-
2021-02-06
Registered in v-safe
-
2021-02-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2021-02-07
Survey response — days 1–6 daily, dose 2MedDRA: Upper-airway cough syndrome — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessFree text: Post nasal dripMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-03-01
-
2021-03-08
Survey response — day 35, dose 2MedDRA: Pain — Feeling: Good · Be unable to do your normal daily activitiesFree text: Body achesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-17
- 2021-05-03
- 2021-08-02
-
2022-01-12
Dose 3 — Moderna
- 2022-01-12
-
2022-01-13
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-01-14
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-01-15
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-16
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-01-17
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-01-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2022-01-20
-
2022-01-26
Survey response — day 14, dose 3MedDRA: Cough — Feeling: GoodFree text: CoughMedDRA releases: 2024-11 · check-in free text available
- 2022-02-02
-
2022-02-09
Survey response — day 28, dose 3MedDRA: Cough, Nasopharyngitis, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Mild cold (runny nose and cough)MedDRA releases: 2024-11 · check-in free text available
-
2022-02-09
Report sent to call center — day 28, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-02-16
Survey response — day 35, dose 3MedDRA: Rhinorrhoea, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Runny nose. Tested positive for covidMedDRA releases: 2024-11 · check-in free text available
- 2022-02-23
- 2022-03-28
- 2022-04-13
- 2022-07-14
-
2023-01-13
Survey response — 12 months, dose 3MedDRA: Autoimmune disorder, Pregnancy, Sjogren's syndrome — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-13
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-16
- 2023-01-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-11 | Pfizer-BioNTech | |
| 2 | 2021-02-01 | Pfizer-BioNTech | |
| 3 | 2022-01-12 | Moderna | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Post nasal drip
Release 5 — day 35, dose 2
Symptoms: Body aches
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Sore throat
Release 11 — day 14, dose 3
Symptoms: Cough
Release 11 — day 28, dose 3
Symptoms: Mild cold (runny nose and cough)
Release 11 — day 35, dose 3
Symptoms: Runny nose. Tested positive for covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Autoimmune disorder | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sjogren's syndrome | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release